Immunic Inc. (IMUX) proposes public offering

Go back to Immunic Inc. (IMUX) proposes public offering

Immunic, Inc. Announces Proposed Public Offering

May 28, 2025 4:02 PM EDT

NEW YORK, May 28, 2025 /PRNewswire/ -- Immunic, Inc. ("Immunic" or the "Company") (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for... More